14-day Premium Trial Subscription Try For FreeTry Free
Revenue at OPKO Health (NASDAQ: OPK) rose 33% year over year in the second quarter as the test-maker sold 2.2 million of its COVID-19 molecular tests. The pandemic remains a double-edged sword for OP
OPKO Health's (OPK) second-quarter results benefit from increase in RAYALDEE prescriptions.

Wall Street Breakfast: Big Beats From Big Tech

07:04am, Friday, 31'st Jul 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify (click the highlighted links).
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 30) Achieve Life Sciences Inc (NASDAQ: ACHV) Annexon Inc (NASDAQ: ANNX) (IPOed July 24) Atossa Therapeutics...
OPKO Health, Inc. (NASDAQ:OPK) Q2 2020 Earnings Conference Call July 30, 2020 4:45 PM ET Company Participants Yvonne Briggs – LHA, Investor Relations Phillip Frost – Chairman and Chief Executive O
Conference call begins at 4:45 p.m. Eastern time todayMIAMI , July 30, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months e
OPKO Health's (OPK) second-quarter results are likely to reflect solid performance from Products segment and RAYALDEE.

3 Great Stocks Under $10 | The Motley Fool

11:15am, Wednesday, 29'th Jul 2020
Investors can pick up a sizable number of shares in great companies without paying a fortune.
Here's why this healthcare company that is testing for COVID-19 in NBA and NFL players is a strong buy.

Biotech Bonanza - Second Half Outlook

08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
So far Monday, July 27, NASDAQ is up 2.28% and the S&P is up 0.89%. Here are this morning’s most
Opko Health Inc. (NASDAQ: OPK) shares are trading higher on Monday. The stock has surged recently after it was announced the company will be involved in NFL coronavirus testing.Opko Health is a divers
MIAMI, July 27, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended June 30, 2020, as well as discuss financial guidance
In the latest trading session, OPKO Health (OPK) closed at $5.60, marking a +0.72% move from the previous day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE